• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Abac backs PronoKal MBO

  • Amedeo Goria
  • Amedeo Goria
  • 04 April 2017
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Private equity fund manager Abac Capital has backed the management buyout of Spanish dietary treatments developer PronoKal Group.

As part of the deal, the GP fully acquired the business alongside the management team from the company's founders. Financial details surrounding the transaction have not been disclosed, but the fund manager deployed capital via its SICAR vehicle, Abac Solution, which usually provides equity tickets of up to €50m. According to a report in local publication El Confidencial and shared by the GP on its LinkedIn page, the deal valued the company at €100m EV. Following the transaction, the management team will continue to head the business.

The new shareholders are keen on boosting the company's presence in its core markets across Europe and Latin America, including the UK, Belgium, the Netherlands, Mexico, Argentina, Peru and Brazil. Furthermore, the managers are willing to expand across new markets such as Colombia, Chile and Italy with the aim to double the company's revenue base within the next five years.

PronoKal Group

  • DEAL:

    MBO

  • LOCATION:

    Barcelona

  • SECTOR:

    Specialised consumer services

  • FOUNDED:

    2004

  • TURNOVER:

    €42m

  • STAFF:

    2,500

Spun out from Apax Partners Espana in 2015, Abac is a Barcelona-based mid-cap private equity house managed by Oriol Pinya, Borja Martínez de la Rosa and Javier Rigau. The GP held a final close on €320m for its maiden vehicle in May 2016.

The deal is the third acquisition for the Spanish GP, following the purchase of auto parts producer Metalcoucho in August 2015 and furnishing manufacturer Figueras International Seating in October 2015.

Company
Founded in 2004, PronoKal develops a protein-based dietary treatment targeting obese and overweight people. Its offering includes nutritional products, medical supervision, personal training and coaching services.

According to a statement, the company generated a turnover of €42m in 2016 and currently employs 2,500 doctors. Based in Barcelona, the company also has a presence in 15 countries across Europe and Latin America, in which it generates 51% of its revenues.

People
Abac Capital – Oriol Pinya (founding partner).
PronoKal Group – Joan Fondevila (CEO).

Advisers
Equity – KPMG (financial due diligence); EY (legal); Antares Consulting (commercial due diligence).
Company – PwC (financial due diligence); M&A Fusiones y Adquisiciones (financial due diligence); Crowe Horwath (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Consumer
  • Southern Europe
  • Spain

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013